Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SEELEY, MARTHA

NPI: 1417920224 · GLASGOW, KY 42141 · Family Medicine Physician · NPI assigned 02/10/2006

$777K
Total Medicaid Paid
16,207
Total Claims
7,621
Beneficiaries
9
Codes Billed
2018-01
First Month
2019-06
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 9,767 $460K
2019 6,440 $318K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 7,151 3,023 $269K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,496 1,270 $225K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1,623 780 $190K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 873 469 $39K
80305 3,535 1,709 $38K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 187 152 $10K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 221 107 $6K
36415 Collection of venous blood by venipuncture 104 95 $330.25
81025 17 16 $114.23